Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains (Q28266980)

https://api.crossref.org/works/10.1074%2FJBC.M604980200

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

Inhibition of hepatitis B virus replication by APOBEC3G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

HIV-1 Vif Blocks the Antiviral Activity of APOBEC3G by Impairing Both Its Translation and Intracellular Stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

APOBEC3G targets human T-cell leukemia virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

Complementary function of the two catalytic domains of APOBEC3G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

DNA deamination mediates innate immunity to retroviral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

Hypermutation of HIV-1 DNA in the Absence of the Vif Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

Cytidine deamination of retroviral DNA by diverse APOBEC proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

Cytidine deaminase. The 2.3 A crystal structure of an enzyme: transition-state analog complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200

Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604980200